Efficacy and Safety of F-18 FPCIT PET in Parkinson's Disease and Essential Tremor Patients
NCT ID: NCT00468078
Last Updated: 2016-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
78 participants
INTERVENTIONAL
2006-11-30
2007-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Somatotopy in Parkinson's Disease
NCT04876404
The Effects of fNIRS-based Neurofeedback Training on Balance and Gait in Parkinson's Disease
NCT05800470
PET Study of Non-Motor Symptoms of Parkinson Disease
NCT01565473
[18F] - FD17 PET Imaging of α-synuclein: A Clinical Study in α-synucleinopathy Patients
NCT06738862
Research Involving Subjects With Parkinson's Disease, Alzheimer Disease and Healthy Controls
NCT01461109
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Parkinson's disease
PET/CT
10min acquisition, 90min after injection of F-18 FPCIT
F-18 FPCIT
5mCi, intravenous injection
B
ET+Normal
PET/CT
10min acquisition, 90min after injection of F-18 FPCIT
F-18 FPCIT
5mCi, intravenous injection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PET/CT
10min acquisition, 90min after injection of F-18 FPCIT
F-18 FPCIT
5mCi, intravenous injection
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male or female with age over 40 years
* Clinical diagnosis of Parkinson's disease
* Ability to give informed consent
Essential tremor
* Male or female with age over 40 years
* Clinical diagnosis of Essential tremor
* Ability to give informed consent
Healthy volunteers
* Male or female with age over 40 years
* No any symptoms or sign suggesting Parkinson's disease or essential tremor
* Ability to give informed consent
Exclusion Criteria
* Current pregnancy and breast feeding
* Current or past medical history of cardiac and neuropsychiatric disease
* Clinical evidence of dementia
* Inability to hold antiparkinsonian medication
* History of surgical therapy for tremor
* Severe or unstable medical or psychiatric condition
* Medication affecting CNS in last 6 months(e.g. CNS stimulants, sympathomimetics)
* Prior participation in other research protocol within 30 days
Healthy volunteers
* Current pregnancy and breast feeding
* Current or past medical history of cardiac and neuropsychiatric disease
* Severe or unstable medical or psychiatric condition
* Drug abuse or medication affecting CNS (e.g. CNS stimulants, sympathomimetics) within 6 months
* Prior participation in other research protocol within 30 days
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Asan Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jae Seung Kim
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jae Seung Kim, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Asan Medical Center
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kazumata K, Dhawan V, Chaly T, Antonini A, Margouleff C, Belakhlef A, Neumeyer J, Eidelberg D. Dopamine transporter imaging with fluorine-18-FPCIT and PET. J Nucl Med. 1998 Sep;39(9):1521-30.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FPCITKR001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.